The Joint Pain Injections Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market size of joint pain injections has seen a swift expansion in recent years. Its growth is projected to rise from $5.6 billion in 2024 to $6.17 billion in 2025, with a compound annual growth rate (CAGR) of 10.1%.
The global market for joint pain injections is projected to reach $9.81 billion by 2029, increasing at a compound annual growth rate (CAGR) of 12.3%.
Download Your Free Sample of the 2025 Joint Pain Injections Market Report and Uncover Key Trends Now!The key drivers in the joint pain injections market are:
• Expansion of telehealth services
• Personalized pain management strategies
• Increasing focus on patient education and empowerment
• Advancements in sustainable healthcare practices
The joint pain injections market covered in this report is segmented –
1) By Type Of Injection: Steroid Joint Injection, Hyaluronic Acid Injections, Platelet-Rich Plasma (PRP) Injections, Placental Tissue Matrix (PTM) Injections, Other Type Of Injections
2) By Joint Type: Hip Joint, Knee And Ankle, Shoulder And Elbow, Facet Joints Of The Spine, Other Joint Types
3) By Distribution channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
The key trends in the wound closure devices market are:
• The adoption of regenerative medicine is a key emerging trend.
• Personalized pain management is becoming increasingly popular.
• The use of innovative injection materials is a significant new direction.
• There is an increasing focus on artificial intelligence-enhanced injections.
Major companies in the joint pain injections market are:
• Seikagaku Corporation
• Flexion Therapeutics Inc.
• Zimmer Biomet Holdings Inc.
• Sanofi S.A.
• Anika Therapeutics Inc.
• Abbvie Inc.
• Bioventus Inc.
• Eli Lilly and Company
• Ferring Pharmaceuticals Inc.
• Pfizer Inc.
• Teva Pharmaceutical Industries Limited
• Johnson & Johnson Services Ltd.
• Merck & Co. Inc.
• GlaxoSmithKline plc
• Novartis AG
• AstraZeneca plc
• Roche Holding AG
• Boehringer Ingelheim International GmbH
• Takeda Pharmaceutical Company Limited
• Bayer AG
• Astellas Pharma Inc.
• Daiichi Sankyo Company Limited
• Eisai Co. Ltd.
• Ipsen SA
• Mallinckrodt Pharmaceuticals Ltd.
• Mylan N.V.
• Sun Pharmaceutical Industries Ltd.
• Wockhardt Ltd.
• Zydus Lifesciences Limited
North America was the largest region in the joint pain injections market in 2024